Distinct and Shared Determinants of Cardiomyocyte Contractility in Multi-Lineage Competent Ethnically Diverse Human iPSCs

• Published in: Scientific reports 2016-12, Vol.6 (1), p.37637, Article 37637
• Main Authors: Tomov, Martin L., Olmsted, Zachary T., Dogan, Haluk, Gongorurler, Eda, Tsompana, Maria, Otu, Hasan H., Buck, Michael, Chang, Eun-Ah, Cibelli, Jose, Paluh, Janet L.
• Format: Article
• Language: English
• Subjects: 13/100; 13/105; 13/106; 13/107; 14/19; 45/15; 45/90; 45/91; 631/114/2413; 631/532; Bioinformatics; Cardiomyocytes; Hispanic Americans; Humanities and Social Sciences; Karyotypes; multidisciplinary; Muscle contraction; Pancreas; Pluripotency; Precision medicine; Ribonucleic acid; RNA; Science; Smooth muscle; Stem cells; Teratoma
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep37637

The realization of personalized medicine through human induced pluripotent stem cell (iPSC) technology can be advanced by transcriptomics, epigenomics, and bioinformatics that inform on genetic pathways directing tissue development and function. When possible, population diversity should be included in new studies as resources become available. Previously we derived replicate iPSC lines of African American, Hispanic-Latino and Asian self-designated ethnically diverse (ED) origins with normal karyotype, verified teratoma formation, pluripotency biomarkers, and tri-lineage in vitro commitment. Here we perform bioinformatics of RNA-Seq and ChIP-seq pluripotency data sets for two replicate Asian and Hispanic-Latino ED-iPSC lines that reveal differences in generation of contractile cardiomyocytes but similar and robust differentiation to multiple neural, pancreatic, and smooth muscle cell types. We identify shared and distinct genes and contributing pathways in the replicate ED-iPSC lines to enhance our ability to understand how reprogramming to iPSC impacts genes and pathways contributing to cardiomyocyte contractility potential.